Evaluating Clinical Trial Designs for Investigational Treatments of Ebola Virus Disease

PLoS Medicine

Volumn 12, Issue 4, 2015, Pages

  Cooper, Ben S ^a,b   Boni, Maciej F ^b,c   Pan ngum, Wirichada ^d   Day, Nicholas P J ^a,b   Horby, Peter W ^b   Olliaro, Piero ^b,e   Lang, Trudie ^b   White, Nicholas J ^a,b   White, Lisa J ^a,b   Whitehead, John ^f  

^a MAHIDOL OXFORD TROPICAL MEDICINE RESEARCH UNIT   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^d MAHIDOL UNIVERSITY   (Thailand)

^e UNICEF   (United States)

^f LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL (TOPIC); EBOLA HEMORRHAGIC FEVER; HEALTH PROGRAM; HUMAN; INFECTION PREVENTION; OUTCOME ASSESSMENT; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); STUDY DESIGN; SURVIVAL; TREATMENT RESPONSE; DRUG SCREENING; EBOLAVIRUS; EPIDEMIC; EVALUATION STUDY; EXPERIMENTAL THERAPY; HEALTH CARE QUALITY; HEMORRHAGIC FEVER, EBOLA; METHODOLOGY; MORTALITY; PROCEDURES; TREATMENT OUTCOME; VIROLOGY;

ANTIBODY; ANTIVIRUS AGENT;

ANTIBODIES; ANTIVIRAL AGENTS; CLINICAL TRIALS AS TOPIC; DRUG EVALUATION; EBOLAVIRUS; EPIDEMICS; HEMORRHAGIC FEVER, EBOLA; HUMANS; RESEARCH DESIGN; STANDARD OF CARE; THERAPIES, INVESTIGATIONAL; TREATMENT OUTCOME;

EID: 84930535975     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001815     Document Type: Article

References (18)

1. WHO Ebola Response Team (2014) Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections. N Engl J Med 371: 1481–1495. doi: 10.1056/NEJMoa1411100 25244186
2. Farrar JJ, Piot P, (2014) The Ebola emergency—immediate action, ongoing strategy. N Engl J Med 371: 1545–1546. doi: 10.1056/NEJMe1411471 25244185
3. Heymann DL, (2014) Ebola: learn from the past. Nature 514: 299–300. doi: 10.1038/514299a 25318509
4. Adebamowo C, Bah-Sow O, Binka F, Bruzzone R, Caplan A, et al. (2014) Randomised controlled trials for Ebola: practical and ethical issues. Lancet 384: 1423–1424. doi: 10.1016/S0140-6736(14)61734-7 25390318
5. Joffe S, (2014) Evaluating novel therapies during the Ebola epidemic. JAMA 312: 1299–1300. doi: 10.1001/jama.2014.12867 25211645
6. Rid A, Emanuel EJ, (2014) Ethical considerations of experimental interventions in the Ebola outbreak. Lancet 384: 1896–1899. doi: 10.1016/S0140-6736(14)61315-5 25155413
7. Whitehead J, (1997) The design and analysis of sequential clinical trials, revised 2nd edition. Chichester: Wiley.
8. Whitehead J, (2011) Group sequential trials revisited: simple implementation using SAS. Stat Methods Med Res 20: 635–656. doi: 10.1177/0962280210379036 20876163
9. Bross I, (1952) Sequential medical plans. Biometrics 8: 188–205.
10. Whitehead J, Todd S, (2004) The double triangular test in practice. Pharm Stat 3: 39–49.
11. Whitehead J, Matsushita T, (2003) Stopping clinical trials because of treatment ineffectiveness: a comparison of a futility design with a method of stochastic curtailment. Stat Med 22: 677–687. 12587099
12. R Core Team (2014) R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing.
13. Fairbanks K, Madsen R, (1982) P values for tests using a repeated significance test design. Biometrika 69: 69–74.
14. Jovic G, Whitehead J, (2010) An exact method for analysis following a two-stage phase II cancer clinical trial. Stat Med 29: 3118–3125. doi: 10.1002/sim.3837 21170906
15. Clopper CJ, Pearson ES, (1934) The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 26: 404–413.
16. Rout CC, Rocke DA, Levin J, Gouws E, Reddy D, (1993) A reevaluation of the role of crystalloid preload in the prevention of hypotension associated with spinal anesthesia for elective cesarean section. Anesthesiology 79: 262–269. 8192733
17. Rosenberger WF, Stallard N, Ivanova A, Harper CN, Ricks ML, (2001) Optimal adaptive designs for binary response trials. Biometrics 57: 909–913. 11550944
18. Magirr D, Jaki T, Whitehead J, (2012) A generalized Dunnett test for multiarm-multistage clinical studies with treatment selection. Biometrika 99:494–501.